Dr. Reddy's Allots 6,730 Equity Shares Under ESOPs
Dr. Reddy's Laboratories Limited allotted 6,730 equity shares on June 19, 2026, under its ESOP schemes. This issuance increases the total issued shares to 83,46,76,800, with a total issued share capital of Rs. 83,46,76,800/-.
The allotment of a small number of shares under ESOPs is a routine event and has a minimal impact on the company's overall share capital and financial performance.
The announcement is a routine allotment of shares under employee stock option schemes, which is a standard corporate action and does not significantly impact the company's financials or operations in a positive or negative way.
Dr. Reddy's Laboratories Limited has allotted 6,730 equity shares of Re.1/- each, fully paid up, on June 19, 2026. This allotment is pursuant to the exercise of stock options by eligible employees under the Dr. Reddy’s Employees Stock Option Scheme, 2002 and Dr. Reddy’s Employees ADR Stock Option Scheme, 2007.
The issuance details include 2,455 shares at an exercise price of Re.1/- each with no premium, 2,000 shares at Rs. 562.80/- each with a premium of Rs. 561.80/-, and 2,275 shares at Rs. 735.80/- each with a premium of Rs. 734.80/-
Following this allotment, the total issued shares of the company now stand at 83,46,76,800. The total issued share capital after this issue is Rs. 83,46,76,800/-. The shares allotted rank pari passu with the existing equity shares.
What to do with a filing like this
Dr. Reddy's Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under designated person disclosures. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Reddy's Laboratories Limited. Read the original for the full detail.